HUP0501084A2 - New pharmaceutical compositions of high effectivity - Google Patents

New pharmaceutical compositions of high effectivity

Info

Publication number
HUP0501084A2
HUP0501084A2 HU0501084A HUP0501084A HUP0501084A2 HU P0501084 A2 HUP0501084 A2 HU P0501084A2 HU 0501084 A HU0501084 A HU 0501084A HU P0501084 A HUP0501084 A HU P0501084A HU P0501084 A2 HUP0501084 A2 HU P0501084A2
Authority
HU
Hungary
Prior art keywords
pharmaceutical compositions
new pharmaceutical
high effectivity
effectivity
new
Prior art date
Application number
HU0501084A
Other languages
Hungarian (hu)
Inventor
Pal Kocsis
Istvan Dr Tarnawa
Marta Dr Than
Karoly Dr Tihanyi
Gyoergy Dr Nemeth
Original Assignee
Richter Gedeon Nyrt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Nyrt filed Critical Richter Gedeon Nyrt
Priority to HU0501084A priority Critical patent/HUP0501084A2/en
Publication of HU0501084D0 publication Critical patent/HU0501084D0/en
Priority to PCT/HU2006/000102 priority patent/WO2007060491A2/en
Publication of HUP0501084A2 publication Critical patent/HUP0501084A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/428—Thiazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
HU0501084A 2005-11-23 2005-11-23 New pharmaceutical compositions of high effectivity HUP0501084A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
HU0501084A HUP0501084A2 (en) 2005-11-23 2005-11-23 New pharmaceutical compositions of high effectivity
PCT/HU2006/000102 WO2007060491A2 (en) 2005-11-23 2006-11-23 Pharmaceutical compositions comprising a sodium channel blocker in combination with a mao-b- inhibitor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU0501084A HUP0501084A2 (en) 2005-11-23 2005-11-23 New pharmaceutical compositions of high effectivity

Publications (2)

Publication Number Publication Date
HU0501084D0 HU0501084D0 (en) 2006-01-30
HUP0501084A2 true HUP0501084A2 (en) 2008-05-28

Family

ID=89986416

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0501084A HUP0501084A2 (en) 2005-11-23 2005-11-23 New pharmaceutical compositions of high effectivity

Country Status (2)

Country Link
HU (1) HUP0501084A2 (en)
WO (1) WO2007060491A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090062400A1 (en) * 2007-09-05 2009-03-05 Laurence Oron Method of treating glaucoma using rasagiline
US8080584B2 (en) 2009-01-23 2011-12-20 Teva Pharmaceuticals Industries, Ltd. Delayed release rasagiline citrate formulation
US9308182B2 (en) * 2012-08-17 2016-04-12 Teva Pharmaceutical Industries, Ltd. Parenteral formulations of rasagiline

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1567152T1 (en) * 2002-11-15 2013-10-30 Teva Pharmaceutical Industries Ltd. Use of rasagiline with riluzole to treat amyotrophic lateral sclerosis
WO2007054975A1 (en) * 2005-11-08 2007-05-18 Panacea Biotec Ltd Pharmaceutical compositions for the treatment of cardiovascular and other associated disorders

Also Published As

Publication number Publication date
WO2007060491A3 (en) 2008-01-03
HU0501084D0 (en) 2006-01-30
WO2007060491A2 (en) 2007-05-31

Similar Documents

Publication Publication Date Title
HK1244267A1 (en) Pharmaceutical compositions comprising (r)-n-methylnaltrexone
ZA200900347B (en) Preparation of pharmaceutical compositions
PL2335782T3 (en) Use of compositions comprising HFCO-1233zd
GB0513692D0 (en) Novel pharmaceutical compositions
IL179627A0 (en) Particulate-stabilized injectable pharmaceutical compositions of posaconasole
GB0321607D0 (en) Manufacture of pharmaceutical compositions
IL195541A0 (en) Pharmaceutical compositions of memantine
EP1765283A4 (en) Pharmaceutical compositions
ZA200706698B (en) New pharmaceutical compositions for treatment of thrombosis
GB0409703D0 (en) Pharmaceutical compositions
IL189614A0 (en) Pharmaceutical compositions of telmisartan
GB0408308D0 (en) Pharmaceutical compositions
IL188352A0 (en) Pharmaceutical compositions
IL187748A0 (en) Pharmaceutical compositions containing misoprostal
ZA200804103B (en) Pharmaceutical compositions
IL185197A0 (en) Ophthalmological pharmaceutical compositions
GB0405033D0 (en) Novel pharmaceutical compositions
GB0406378D0 (en) Novel pharmaceutical compositions
EP1805154A4 (en) Pharmaceutical compositions
IL183930A0 (en) Use of cladribine for preparation of pharmaceutical compositions
EP1933837A4 (en) Liquid pharmaceutical compositions of nimodipine
EP1971327A4 (en) Pharmaceutical compositions of ilaprazole
EP2114374A4 (en) Pharmaceutical compositions of entacapone
GB0522045D0 (en) Pharmaceutical compositions
IL192091A0 (en) Pharmaceutical compositions

Legal Events

Date Code Title Description
FA9A Lapse of provisional patent protection due to relinquishment or protection considered relinquished
FA9A Lapse of provisional patent protection due to relinquishment or protection considered relinquished